Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
242K
-
Shares change
-
-8.27K
-
Total reported value, excl. options
-
$22.3M
-
Value change
-
-$579K
-
Number of buys
-
1
-
Number of sells
-
-3
-
Price
-
$92.24
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2023
5 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q4 2023.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 242K shares
of 62.5M outstanding shares and own 0.39% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.58M shares), VANGUARD GROUP INC (6.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.43M shares), FMR LLC (4.35M shares), WELLINGTON MANAGEMENT GROUP LLP (4.28M shares), Rock Springs Capital Management LP (2.88M shares), STATE STREET CORP (2.42M shares), Pictet Asset Management Holding SA (1.75M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.73M shares), and T. Rowe Price Investment Management, Inc. (1.6M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.